Literature DB >> 8695372

Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China.

J M Yuan1, S Govindarajan, B E Henderson, M C Yu.   

Abstract

Southern Guangxi, China has one of the highest incidences of hepatocellular carcinoma (HCC) in the world. Serum samples collected from subjects of an earlier case-control study (39 cases, 41 controls) and from a random sampling of a residential male cohort (n = 100) were tested for antibodies for the hepatitis C virus (anti-HCV) using ELISA version 2.0 with confirmation by RIBA version 2.0. Only one of 141 (0.7%, upper 95% confidence limit, 3.2%) control subjects and none of 39 (upper 95% confidence limit, 6.07%) HCC cases tested positive for anti-HCV. Our results indicate that hepatitis C infection is not an important environmental determinant of HCC risk in this hyperendemic region.

Entities:  

Mesh：

Year:  1996        PMID： 8695372      PMCID： PMC2074655          DOI： 10.1038/bjc.1996.389

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  24 in total

1.  Two Cases of Puerperal Anuria in which the Renal Capsule was incised and Portions of the Kidney Substance removed for Examination.

Authors:  C White
Journal:  Proc R Soc Med       Date:  1919

2.  A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi Province, southern China.

Authors:  H Okuno; Z C Xie; B Y Lu; X Qin; M Takasu; H Kano; Y Shiozaki; K Inoue
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

3.  Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan.

Authors:  K Hamasaki; K Nakata; T Tsutsumi; S Tsuruta; K Nakao; Y Kato; M Shima; T Koji; S Nagataki
Journal:  J Med Virol       Date:  1993-06       Impact factor: 2.327

4.  Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan.

Authors:  J E Jeng; J F Tsai
Journal:  J Med Virol       Date:  1991-05       Impact factor: 2.327

5.  Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.

Authors:  K Tanaka; T Hirohata; S Koga; K Sugimachi; T Kanematsu; F Ohryohji; H Nawata; H Ishibashi; Y Maeda; H Kiyokawa
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

6.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.

Authors:  R K Ross; J M Yuan; M C Yu; G N Wogan; G S Qian; J T Tu; J D Groopman; Y T Gao; B E Henderson
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

7.  Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan.

Authors:  K Nakashima; S Kashiwagi; J Hayashi; A Noguchi; M Hirata; W Kajiyama; K Urabe; K Minami; Y Maeda
Journal:  Am J Epidemiol       Date:  1992-11-01       Impact factor: 4.897

8.  [Etiologic study on the relationship between HBV, HCV and HCC].

Authors:  B Ye; J Shen; Y Xu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  1994-06

9.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors:  G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

10.  A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan.

Authors:  C C Chang; M W Yu; C F Lu; C S Yang; C J Chen
Journal:  J Med Virol       Date:  1994-07       Impact factor: 2.327
View more
  5 in total

1.  Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.

Authors:  Woon-Puay Koh; Jian-Min Yuan; Renwei Wang; Sugantha Govindarajan; Rowena Oppenheimer; Zhen Quan Zhang; Mimi C Yu; Sue Ann Ingles
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

2.  Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China.

Authors:  Li Xu; Guoqing Qian; Lili Tang; Jianjia Su; Jia-Sheng Wang
Journal:  J Hepatol       Date:  2010-06-20       Impact factor: 25.083

3.  Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA.

Authors:  Simona Ognjanovic; Jian-Min Yuan; Ann K Chaptman; Yunhua Fan; Mimi C Yu
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

Review 4.  Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors:  Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal:  J Epidemiol       Date:  2011-10-22       Impact factor: 3.211

5.  Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis.

Authors:  Zhonglan Wu; Lijia Cui; Weiming Zhao; Dongzhi Yang; Hui Chen; Ruiqing Wang; Xuemin Wang; Linqi Zhang; Tianhua He
Journal:  Virol J       Date:  2016-10-18       Impact factor: 4.099
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.